Risk Factors for Glaucoma in Musicians

May 22, 2015 updated by: Henny Beckers
The purpose of this study is to determine the impact of playing wind instruments for the development of ocular hypertension and glaucoma, together with investigating the prevalence of visual problems and eye diseases in (professional) musicians.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Maastricht, Netherlands, 6202 AZ
        • University Eye Clinic, Maastricht University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

(Professional) musicians, who play in symphony or wind orchestras.

Description

Inclusion Criteria:

  • All full time or part time professional players of participating symphony or wind orchestras, including guest players.
  • Retired players, if possible.

Exclusion Criteria:

  • Difficulty in reading or speaking Dutch.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
(Wind) musicians
Members of (professional) orchestras, especially wind instrument players.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
IOP levels, including IOP peaks occurring during or directly after playing, and prevalence of glaucomatous field loss in players of wind instruments.
Time Frame: One hour.
One hour.
IOP peaks and variations during continuous IOP monitoring
Time Frame: 24 hours
Several high-risk participants will be asked their permission to perform continuous IOP monitoring during 24 hours with a sensing contact lens.
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk factors for glaucoma and the prevalence of visual problems and eye disease among (professional) musicians
Time Frame: 2 years
Participants of orchestras will be asked to fill in a questionnaire to collect demographic data together with data on musical history,ophthalmologic history and family history on glaucoma and ocular hypertension. From these participants, a selection will be invited for further screening.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Henny JM Beckers, MD, PhD, Maastricht University Medical Center, NL

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (Actual)

February 1, 2014

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

August 10, 2012

First Submitted That Met QC Criteria

August 16, 2012

First Posted (Estimate)

August 17, 2012

Study Record Updates

Last Update Posted (Estimate)

May 25, 2015

Last Update Submitted That Met QC Criteria

May 22, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NL25853.068.09/MEC09-2-112

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glaucoma

3
Subscribe